Cached score snapshot
US.CRL · Charles River Laboratories
110分制 51.1/110;5D動能v2 3/50;排序分 54.1/160
Score breakdown
避免
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +1.30% | -0.66% / +3.68% | 65.2% | 3.2% | Actual outcome pending · 1 / 3 bars observed |
| 30D observation | +8.66% | -0.25% / +16.67% | 74% | 11% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | +1.46% | -0.51% / +4.10% | 67.5% | 1.9% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-06-10 → 2026-10-15 · 119 archived points · 2 Improving turn signal · 4 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 17.5 · 資金流 11.6 · 5D動能v2 3
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 1.5/5 · 較差
Sub-items
資金流 — 11.6/20 · 較差
Sub-items
institutional
details
warning
市場環境 — 10.2/15 · 一般
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 6.3/10 · 一般
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 17.5/30 · 較差
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 2/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 1.5/5分 資金流分析總分: 11.6/20分 市場環境分析總分: 10.2/15分 催化劑分析: 2/20分 風險管理總分: 6.3/10分 技術信號分析總分: 17.5/30分 情緒分析: 2/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Elevated",
"reason": "risk management score >= 5/10",
"position": {
"score": 1.1,
"details": {
"atrPct": 3.3485255378038,
"turnoverUsdM": 189.60531221345,
"liquidityPoints": 0.4,
"volatilityPoints": 0.7
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.CRL",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 273.7042,
"strength_details": {
"ma_score": 1.5,
"atr_score": 1,
"rsi_score": 3,
"macd_score": 1.5,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1,
"stop_loss_percent": 6.7,
"take_profit_price": 313.5688,
"target_multiplier": 1.9,
"technical_strength": 1.63,
"take_profit_percent": 6.9
},
"positionPoints": 1.1,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 6.6970510756076,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 54.1,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 51.1,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 3
},
"market": {
"ma20": 287.4785,
"ma50": 253.1098,
"close": 293.35,
"prevClose": 291.76,
"avgVolume20": 889547,
"volumeRatio": 0.73,
"changePercent": 0.54
},
"sources": {
"catalyst": "fmp_stable_news_keyword_model_empty",
"sentiment": "fmp_stable_news_keyword_model_empty",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 3,
"details": {
"ret_5d": -0.010323504605107892,
"max_score": 50,
"max_total": 50,
"raw_total": 3,
"vcp_bonus": 0,
"vol_ratio": 0.7005690440060698,
"ret_points": 0,
"vol_points": 0,
"range_ratio": 1.0362875851746665,
"volat_points": 0,
"day_range_pct": 0.03412309411545622,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 3,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 54.1,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 1.5,
"label": "基本面",
"weight": "5/110",
"normalized": 30,
"contribution": 1.5
},
{
"raw": 11.6,
"label": "資金流",
"weight": "20/110",
"normalized": 58,
"contribution": 11.6
},
{
"raw": 10.2,
"label": "市場環境",
"weight": "15/110",
"normalized": 68,
"contribution": 10.2
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 6.3,
"label": "風險管理",
"weight": "10/110",
"normalized": 63,
"contribution": 6.3
},
{
"raw": 17.5,
"label": "技術信號",
"weight": "30/110",
"normalized": 58.33,
"contribution": 17.5
},
{
"raw": 2,
"label": "情緒分析",
"weight": "10/110",
"normalized": 20,
"contribution": 2
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "避免",
"result": 51.1,
"details": [
"基本面分析總分: 1.5/5分",
"資金流分析總分: 11.6/20分",
"市場環境分析總分: 10.2/15分",
"催化劑分析: 2/20分",
"風險管理總分: 6.3/10分",
"技術信號分析總分: 17.5/30分",
"情緒分析: 2/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 1.5,
"資金流": 11.6,
"市場環境": 10.2,
"情緒分析": 2,
"技術信號": 17.5,
"風險管理": 6.3
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "fmp_stable_news_keyword_model_empty",
"articleCount": 0,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "較差",
"items": {
"pbPoints": 0.2,
"pePoints": 0,
"epsPoints": 0,
"roePoints": 0,
"debtPoints": 0.4,
"marginPoints": 0,
"turnoverUsdM": 189.60531221345,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0,
"marketCapPoints": 0.4
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 2.4,
"mfiPoints": 3.2,
"obvPoints": 1.6,
"vwapPoints": 2.4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.CRL",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "一般",
"items": {
"vix": {
"score": 2.4,
"details": {
"source": "twelvedata+fred",
"vixClose": 15.2
}
},
"trend": {
"score": 3.4,
"details": {
"qqq": {
"ma20": 717.7140015000001,
"ma50": 711.03339964,
"name": "QQQ",
"close": 717.66998,
"points": 1.4
},
"spy": {
"ma20": 769.2064939,
"ma50": 756.1394004199999,
"name": "SPY",
"close": 773.16998,
"points": 2
},
"source": "twelvedata+fred"
}
},
"atrPct": 3.3485255378038,
"atrPoints": 2,
"cciPoints": 2.4,
"vixPoints": 2.4,
"marketTrendPoints": 3.4
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 2,
"details": {
"source": "fmp_stable_news_keyword_model_empty",
"articleCount": 0,
"negativeHits": 0,
"positiveHits": 0,
"sentimentScoreRaw": 0
}
},
"sentimentData": {
"raw": [],
"raw_source": [
{
"url": "https://www.prnewswire.com/news-releases/regn-investor-alert-regeneron-pharmaceuticals-inc-investors-with-substantial-losses-have-opportunity-to-lead-the-regeneron-class-action-lawsuit-302869584.html",
"site": "prnewswire.com",
"text": "SAN DIEGO, Sept. 3, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) common stock between August 1, 2025 and May 15, 2026, inclusive (the \"Class Period\"), have until September 14, 2026 to seek appointment as lead plaintiff of the Regeneron class action lawsuit.",
"image": "https://images.financialmodelingprep.com/news/regn-investor-alert-regeneron-pharmaceuticals-inc-investors-with-substantial-20260903.jpg",
"title": "REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Regeneron Class Action Lawsuit",
"symbol": "REGN",
"publisher": "PRNewsWire",
"publishedDate": "2026-09-03 19:10:00"
},
{
"url": "https://247wallst.com/investing/2026/09/03/nvidia-is-now-paying-to-train-plumbers-and-the-stock-that-should-benefit-most-just-hit-a-52-week-low/",
"site": "247wallst.com",
"text": "On September 1, 2026, the Lowe's Foundation announced what it called the nation's largest skilled trades coalition, with NVIDIA (NASDAQ:NVDA | NVDA Price Prediction), AT&T, Bank of America, Carrier, General Motors, DEWALT and Duke Energy signing on to train 1",
"image": "https://images.financialmodelingprep.com/news/nvidia-is-now-paying-to-train-plumbers-and-the-20260903.jpg",
"title": "Nvidia Is Now Paying to Train Plumbers, and the Stock That Should Benefit Most Just Hit a 52-Week Low",
"symbol": "NVDA",
"publisher": "24/7 Wall Street",
"publishedDate": "2026-09-03 19:09:19"
},
{
"url": "https://www.zacks.com/stock/news/2984815/ai-infrastructure-demand-remains-red-hot-hpe-avgo-dell-deliver?cid=CS-STOCKNEWSAPI-FT-stocks_in_the_news-2984815",
"site": "zacks.com",
"text": "The AI trade remains alive and well, with Hewlett Packard Enterprise (HPE), Broadcom (AVGO), and Dell Technologies (DELL) all recently posting strong quarterly results.",
"image": "https://images.financialmodelingprep.com/news/ai-infrastructure-demand-remains-redhot-hpe-avgo-dell-deliver-20260903.jpg",
"title": "AI Infrastructure Demand Remains Red-Hot: HPE, AVGO, DELL Deliver",
"symbol": "HPE",
"publisher": "Zacks Investment Research",
"publishedDate": "2026-09-03 19:06:05"
},
{
"url": "https://www.marketbeat.com/instant-alerts/transcript-docusign-q2-earnings-call-highlights-2026-09-03/",
"site": "marketbeat.com",
"text": "Docusign NASDAQ: DOCU reported second-quarter fiscal 2027 revenue of $876 million, up 9% from a year earlier, as adoption of its Intelligent Agreement Management, or IAM, platform increased and the company expanded its artificial intelligence capabilities and integrations.",
"image": "https://images.financialmodelingprep.com/news/docusign-q2-earnings-call-highlights-20260903.jpg",
"title": "Docusign Q2 Earnings Call Highlights",
"symbol": "DOCU",
"publisher": "MarketBeat",
"publishedDate": "2026-09-03 19:04:45"
},
{
"url": "https://www.marketbeat.com/instant-alerts/transcript-lululemon-athletica-q2-earnings-call-highlights-2026-09-03/",
"site": "marketbeat.com",
"text": "lululemon athletica NASDAQ: LULU reported second-quarter revenue and earnings that fell below its expectations, citing weaker traffic, inconsistent product launches and pressure on brand sentiment in North America and China Mainland. The company lowered its full-year outlook and said it is increasing marketing investment while tightening expenses and inventory management.",
"image": "https://images.financialmodelingprep.com/news/lululemon-athletica-q2-earnings-call-highlights-20260903.jpg",
"title": "lululemon athletica Q2 Earnings Call Highlights",
"symbol": "LULU",
"publisher": "MarketBeat",
"publishedDate": "2026-09-03 19:04:41"
},
{
"url": "https://www.marketbeat.com/instant-alerts/transcript-mamas-creations-q2-earnings-call-highlights-2026-09-03/",
"site": "marketbeat.com",
"text": "Mama's Creations NASDAQ: MAMA reported fiscal second-quarter revenue growth of 55% and said expanded retail distribution, contributions from the Bay Shore acquisition and new product launches helped drive operating leverage and higher profitability.",
"image": "https://images.financialmodelingprep.com/news/mamas-creations-q2-earnings-call-highlights-20260903.jpg",
"title": "Mama's Creations Q2 Earnings Call Highlights",
"symbol": "MAMA",
"publisher": "MarketBeat",
"publishedDate": "2026-09-03 19:04:36"
},
{
"url": "https://www.marketbeat.com/instant-alerts/transcript-zscaler-q4-earnings-call-highlights-2026-09-03/",
"site": "marketbeat.com",
"text": "Zscaler NASDAQ: ZS reported fourth-quarter fiscal 2026 revenue of $898 million, up 25% from a year earlier and 6% sequentially, as the cybersecurity company cited continued demand for its zero-trust platform, data security offerings and AI-related products.",
"image": "https://images.financialmodelingprep.com/news/zscaler-q4-earnings-call-highlights-20260903.jpg",
"title": "Zscaler Q4 Earnings Call Highlights",
"symbol": "ZS",
"publisher": "MarketBeat",
"publishedDate": "2026-09-03 19:04:32"
},
{
"url": "https://www.marketbeat.com/instant-alerts/transcript-asana-q2-earnings-call-highlights-2026-09-03/",
"site": "marketbeat.com",
"text": "Asana NYSE: ASAN reported second-quarter fiscal 2027 revenue of $216.4 million, up 10% year over year and above the high end of its guidance, as the work-management software company cited improving retention, stronger enterprise performance and growing adoption of its artificial intelligence products.",
"image": "https://images.financialmodelingprep.com/news/asana-q2-earnings-call-highlights-20260903.jpg",
"title": "Asana Q2 Earnings Call Highlights",
"symbol": "ASAN",
"publisher": "MarketBeat",
"publishedDate": "2026-09-03 19:04:28"
},
{
"url": "https://www.marketbeat.com/instant-alerts/transcript-guidewire-software-q4-earnings-call-highlights-2026-09-03/",
"site": "marketbeat.com",
"text": "Guidewire Software NYSE: GWRE closed fiscal 2026 with annual recurring revenue, or ARR, above its guidance range, supported by cloud migrations, low customer attrition and demand for newer artificial intelligence and pricing products.",
"image": "https://images.financialmodelingprep.com/news/guidewire-software-q4-earnings-call-highlights-20260903.jpg",
"title": "Guidewire Software Q4 Earnings Call Highlights",
"symbol": "GWRE",
"publisher": "MarketBeat",
"publishedDate": "2026-09-03 19:04:25"
},
{
"url": "https://www.marketbeat.com/instant-alerts/transcript-samsara-q2-earnings-call-highlights-2026-09-03/",
"site": "marketbeat.com",
"text": "Samsara NYSE: IOT reported second-quarter fiscal 2027 results marked by 30% year-over-year growth in annual recurring revenue and revenue, while the provider of connected operations software expanded its large-customer base and maintained GAAP profitability.",
"image": "https://images.financialmodelingprep.com/news/samsara-q2-earnings-call-highlights-20260903.jpg",
"title": "Samsara Q2 Earnings Call Highlights",
"symbol": "IOT",
"publisher": "MarketBeat",
"publishedDate": "2026-09-03 19:04:13"
}
],
"data_source": "fmp_stable_news_keyword_model_empty",
"article_count": 0,
"negative_hits": 0,
"positive_hits": 0,
"recomputed_at_score": true,
"sentiment_score_raw": 0,
"source_article_count": 10,
"discarded_article_count": 10
},
"sentimentPoints": 2
}
},
"技術信號": {
"max": 30,
"raw": 17.5,
"grade": "較差",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 1.2000000000000002,
"vcpPoints": 2.2,
"macdPoints": 2.4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 2.2,
"vcp_reason": "波幅收縮(27.5%→7.6%);跌縮量(近10日3日);站上MA50;Ready=Y;Confirm=N",
"vcp_metrics": {
"up_days": 4,
"vol_ref": 933993.3333333334,
"down_days": 5,
"vcp_ready": true,
"above_ma50": true,
"avg_vol_10": 880700,
"avg_vol_20": 922600,
"avg_vol_30": 933993.3333333334,
"range_pct_10": 0.07635929516416236,
"range_pct_20": 0.16199082454437283,
"range_pct_30": 0.2748594077089004,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": true,
"down_shrink_ok": true,
"up_expand_days": 0,
"breakout_20d_ok": false,
"vol_ratio_10_30": 0.9429403493244063,
"dist_to_20d_high": 0.03283765784181202,
"down_shrink_days": 3,
"breakout_level_20d": 303.31,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 0.2778121942438055
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": true
},
"kdjAdxPoints": 0.5,
"rsiKdjPoints": 2.4,
"volumeWeight": 2,
"maCrossPoints": 1.6,
"shortRsiPoints": 0.4,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0,
"volumePointsTechnical": 0.4
}
},
"風險管理": {
"max": 10,
"grade": "一般",
"items": {
"position": {
"score": 1.1,
"details": {
"atrPct": 3.3485255378038,
"turnoverUsdM": 189.60531221345,
"liquidityPoints": 0.4,
"volatilityPoints": 0.7
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.CRL",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 273.7042,
"strength_details": {
"ma_score": 1.5,
"atr_score": 1,
"rsi_score": 3,
"macd_score": 1.5,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1,
"stop_loss_percent": 6.7,
"take_profit_price": 313.5688,
"target_multiplier": 1.9,
"technical_strength": 1.63,
"take_profit_percent": 6.9
},
"positionPoints": 1.1,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 6.6970510756076,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 92.86,
"atr": {
"atr": 9.8229,
"rule": "ATR / current price; lower volatility scores higher",
"score": 4,
"atr_pct": 3.35
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "平衡",
"score": 6,
"value": 46.95
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "輕微流入",
"score": 6,
"value": 0.173
},
"kdj": {
"d": 52.88,
"j": 36.51,
"k": 47.42,
"rule": "Cursor_18.24 K/D cross",
"score": 0,
"signal": "死叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "入貨中",
"score": 8,
"value": 63.71
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 4,
"trend": "弱勢",
"value": 9900345,
"recentSlope": -162605.5,
"previousSlope": 465390
},
"rsi": 60.51,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 4,
"trend": "下降",
"value": 299.7996,
"position": "SAR喺價上",
"distancePct": 2.2,
"previousTrend": "下降"
},
"ma50": 253.1098,
"macd": {
"macd": 12.117170182066559,
"trend": "中性偏多",
"signal": 14.493831456541612,
"histogram": -2.376661274475053
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 6,
"value": 287.0049,
"position": "連續1-2日>VWAP",
"consecutiveAbove": 2
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "空升",
"ratio": 0.73,
"score": 2,
"avgVolume": 889547,
"currentVolume": 646345
},
"derived": {
"ma20": 287.4785,
"ma50": 253.1098,
"prevClose": 291.76,
"avgVolume10": 839405,
"avgVolume20": 889547,
"changePercent": 0.54,
"avgVolumeForScore": 889547
},
"ma_cross": {
"ma20": 287.4785,
"ma50": 253.1098,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "多頭",
"score": 4,
"prevMa20": 286.0865,
"prevMa50": 251.2848,
"spreadPct": 13.58,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 271.6414,
"upper": 303.3156,
"position": "上半部"
},
"rsi_short": 46.68,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 0.73
}
}
}
Raw metrics JSON
{
"close": 293.35,
"volume": 646345,
"changePercent": 0.54
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.